{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:52:23Z","timestamp":1769514743590,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001186","name":"Australian Cystic Fibrosis Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001186","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jcf.2023.01.016","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T07:22:39Z","timestamp":1678432959000},"page":"3-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Glucose abnormalities in cystic fibrosis \u2013 how best to measure them, and what is to be done about them?"],"prefix":"10.1016","volume":"22","author":[{"given":"Dr Shihab","family":"Hameed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2023.01.016_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2023.01.016_bib0002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2265.2002.01484.x","article-title":"The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis","volume":"56","author":"Ripa","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7006","key":"10.1016\/j.jcf.2023.01.016_bib0003","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: five year prospective study","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jcf.2023.01.016_bib0004","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"159","key":"10.1016\/j.jcf.2023.01.016_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0293-2020","article-title":"Cystic fibrosis-related diabetes and lung disease: an update","volume":"30","author":"Prentice","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2023.01.016_bib0006","unstructured":"Hameed S, Robinson P. Cystic fibrosis-related diabetes mellitus. 2023. In: UpToDate [Internet]. Available from: https:\/\/www.uptodate.com\/contents\/cystic-fibrosis-related-diabetes-mellitus."},{"issue":"7716","key":"10.1016\/j.jcf.2023.01.016_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(71)92303-8","article-title":"Diabetes mellitus in American (Pima) Indians","volume":"2","author":"Bennett","year":"1971","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcf.2023.01.016_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcf.2023.01.016_bib0009","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2004.01219.x","article-title":"Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients","volume":"21","author":"Dobson","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcf.2023.01.016_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.07.014","article-title":"Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes","author":"Potter","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2023.01.016_bib0011","unstructured":"Patient Registry Annual Data Report. 2021."},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2023.01.016_bib0012","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jcf.2019.08.025","article-title":"Continuous glucose monitoring in cystic fibrosis - A practical guide","volume":"18","author":"Chan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.01.016_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.07.013","article-title":"Continuous glucose monitoring versus self-monitoring of blood glucose in the management of Cystic Fibrosis Related Diabetes; a systematic review and meta-analysis","author":"Kumar","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.jcf.2023.01.016_bib0014","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jcf.2023.01.016_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jcf.2023.01.016_bib0016","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/jpc.14340","article-title":"Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus","volume":"55","author":"Sandy","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.016_bib0017","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/193229681200600507","article-title":"Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions","volume":"6","author":"Rasouli","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.jcf.2023.01.016_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.12158","article-title":"Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?","volume":"16","author":"Scheuing","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.016_bib0019","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jcf.2021.03.004","article-title":"Continuous glucose monitoring indices predict poor FEV(1) recovery following cystic fibrosis pulmonary exacerbations","volume":"20","author":"Pallin","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.01.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.08.016","article-title":"Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis","author":"Declercq","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.016_bib0021","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcf.2020.02.009","article-title":"Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932300022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932300022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:48:55Z","timestamp":1761601735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932300022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S156919932300022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.01.016","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Glucose abnormalities in cystic fibrosis \u2013 how best to measure them, and what is to be done about them?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.08.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.07.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.07.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}